Robert J. Motzer, MD

Medical Oncologist

Jack and Dorothy Byrne Chair in Clinical Oncology

Conditions Treated

Pictured: Robert Motzer
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a medical oncologist who is dedicated to improving the lives of people with genitourinary cancer. My primary area of expertise is kidney cancer (renal cell carcinoma). For more than 25 years, I have provided high-quality and compassionate care for people with cancer at MSK.

In addition, I have led more than 75 clinical trials in people with kidney cancer and testicular cancer. These have included national and international multicenter clinical trials. My research has helped identify nine ground-breaking targeted drugs that are effective treatments for people with advanced kidney cancer.

On both a national and international level, I work to improve the quality and delivery of cancer care for people diagnosed with kidney cancer. I developed a risk-based system to help predict treatment outcomes for people taking medications for advanced kidney cancer. This system is used by doctors around the world to guide patient care. I also chair the Kidney Cancer Guidelines Panel in the National Comprehensive Care Network.

I have published more than 500 scientific articles, reviews, chapters, and abstracts. I have given lectures throughout the world, from Japan and China, to Russia and Turkey, to Germany, Spain, and Brazil. I am a recipient of a Career Development Award from the National Institutes of Health, the Willet F. Whitmore Award for Clinical Excellence from Memorial Sloan Kettering, and the Schonfeld Award from the Kidney Cancer Association, a charitable organization dedicated to kidney cancer patient advocacy.

  • Clinical Expertise: Kidney Cancer; Germ Cell Tumors; Testicular Cancer; Immunotherapy
  • Languages Spoken: English
  • Education: MD, University of Michigan Medical School
  • Residencies: Internal Medicine - North Shore University Hospital/Memorial Sloan Kettering Cancer Center
  • Fellowships: Medical Oncology/Hematology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
  • Board Certifications: Internal Medicine; Medical Oncology

See My Colleagues

Publications

Visit PubMed for a full listing of Robert J. Motzer’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.